Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-01
DOI
10.1186/s13046-021-02006-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1
- (2019) Yi Gong et al. Future Oncology
- E-cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma
- (2018) Kerstin W Sinkevicius et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
- (2018) Nicole M. Aiello et al. DEVELOPMENTAL CELL
- EMT in Metastasis: Finding the Right Balance
- (2018) Hin Ching Lo et al. DEVELOPMENTAL CELL
- Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer
- (2018) Maximilian Reichert et al. DEVELOPMENTAL CELL
- The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer
- (2018) Xiao Yang et al. Cancer Medicine
- The roles of ZEB1 in tumorigenic progression and epigenetic modifications
- (2018) Yu Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system
- (2017) Mikael C. Karlsson et al. Molecular Oncology
- Prediction of Lymph Node Metastases in Gastric Cancer by Serum APE1 Expression
- (2017) Xi Wei et al. Journal of Cancer
- Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer
- (2016) Jifeng Peng et al. Future Oncology
- Advances in diagnosis and treatment of metastatic cervical cancer
- (2016) Haoran Li et al. Journal of Gynecologic Oncology
- Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition
- (2016) Xi Wei et al. Oncotarget
- EMT in cervical cancer: Its role in tumour progression and response to therapy
- (2015) Rehana Qureshi et al. CANCER LETTERS
- ZEB1 promotes epithelial–mesenchymal transition in cervical cancer metastasis
- (2015) Jing Ran et al. FERTILITY AND STERILITY
- SET8 induces epithelial-mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1
- (2015) LIEJUN HOU et al. Molecular Medicine Reports
- TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
- (2015) M-F Pang et al. ONCOGENE
- An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer
- (2015) Yong Qin et al. Oncotarget
- Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence
- (2014) Tian Wang et al. HUMAN PATHOLOGY
- The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway
- (2013) Zhilan Chen et al. HUMAN PATHOLOGY
- Synthesis, Biological Evaluation, and Structure–Activity Relationships of a Novel Class of Apurinic/Apyrimidinic Endonuclease 1 Inhibitors
- (2012) Ganesha Rai et al. JOURNAL OF MEDICINAL CHEMISTRY
- APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival
- (2012) Angelo A. Cardoso et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- E-Cadherin Is Transcriptionally Activated via Suppression of ZEB1 Transcriptional Repressor by Small RNA-Mediated Gene Silencing
- (2011) Minami Mazda et al. PLoS One
- ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- (2010) E Sánchez-Tilló et al. ONCOGENE
- The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme
- (2008) Gianluca Tell et al. ANTIOXIDANTS & REDOX SIGNALING
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
- (2008) T. T. Onder et al. CANCER RESEARCH
- Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration
- (2008) G.-M. Zou et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started